About this medicine
- Approved name
- Denagard 45%
- International non-proprietary name (INN) or common name
- tiamulin hydrogen fumarate
- Associated names
- Tiamutin 45%
- Denagard 450 mg/g
- Denagard vet 450 mg/g
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/V/A/114
- Type
- Article 34
Divergent decision referral: initiated in order to obtain harmonisation within the EU of the conditions of authorisation for products already authorised by Member States.
Key dates and outcomes
- Opinion date
- 12/04/2017
- EC decision date
- 14/07/2017